PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 257 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,515,992 | -3.2% | 87,941 | -1.1% | 0.02% | -5.3% |
| Q1 2024 | $2,599,470 | -12.3% | 88,962 | +1.2% | 0.02% | -17.4% |
| Q4 2023 | $2,964,633 | +10.4% | 87,867 | +0.4% | 0.02% | -4.2% |
| Q3 2023 | $2,686,095 | -23.3% | 87,552 | +0.1% | 0.02% | -20.0% |
| Q2 2023 | $3,503,520 | -0.6% | 87,435 | +1.3% | 0.03% | -9.1% |
| Q1 2023 | $3,523,454 | +17.3% | 86,338 | +11.0% | 0.03% | +10.0% |
| Q4 2022 | $3,002,854 | -26.9% | 77,774 | +0.7% | 0.03% | -31.8% |
| Q3 2022 | $4,106,000 | +68.8% | 77,200 | +85.0% | 0.04% | +91.3% |
| Q2 2022 | $2,433,000 | – | 41,726 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ENDOWMENT ADVISERS LP | 3,903 | $113,000 | 100.00% |
| MPM ASSET MANAGEMENT LLC | 824,255 | $23,903,000 | 10.58% |
| Tamarack Capital Management, LLC | 548,900 | $15,918,000 | 8.92% |
| AlpInvest Partners B.V. | 91,700 | $2,659,000 | 2.53% |
| WALL STREET ASSOCIATES | 761,709 | $22,090,000 | 2.25% |
| GILDER GAGNON HOWE & CO LLC | 4,118,765 | $119,444,185,000 | 2.25% |
| Biondo Investment Advisors, LLC | 177,490 | $5,147,000 | 2.23% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 499,829 | $14,495,000 | 1.95% |
| Tygh Capital Management, Inc. | 260,112 | $7,543,000 | 1.67% |
| Visium Asset Management, LP | 2,010,000 | $58,290,000 | 1.36% |